Medpace Holdings is trading 8.3% down now at $541.62 in pre-market as broad risk-off selling continued following the August 18, 2026 technology-led market retreat.
- No new company-specific announcement or earnings release was identified for August 19, 2026.
- Recent coverage highlights valuation concerns after the strong second-quarter beat and guidance increase.
- Profit-taking and broader market positioning are suggested as contributing factors.